The IMPT - Together for Women’s Health Empowerment

Photograph: Edu Lauton https://unsplash.com/@edulauton

Our MPT Database features innovative female-initiated prevention products in the pipeline.

Search for resources on global MPT outreach and advocacy.

View webinars on critical MPT topics from international experts.

Explore the interactive mapping tool which illustrates HIV prevalence in women and the market for contraception.

IMPT video: MPTs for a Better World, new technologies reduce unintended pregnancy, HIV & STIs.

Highlights

Groundbreaking HIV prevention findings: Interim analysis from HPTN 084 study on long-acting injectable cabotegravir in women

Take part in the 2021 HIVR4P Virtual Conference and access the latest in HIV research. Register today!

Evofem Biosciences secures $25M investment to advance its innovative MPT product pipeline

IMPT Director Bethany Young Holt featured in MCI Webinar: MPTs & Male Contraception

On the IMPT Blog: Just Released: Updated MPT Product Development Database

New research by the Population Council estimates the market size for the Dual Prevention Pill (DPP) Regimen

AIDS 2020: Virtual content now available free and on-demand

New open access manuscript co-authored by the IMPT: Towards a roadmap to advance non-hormonal contraceptive multipurpose prevention technologies: Strategic insights from key stakeholders

Read our Call to Action in new commentary co-authored by the IMPT: Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women.

New Policy Brief by WHO & UNAIDS promotes integration of HIV prevention and contraceptive services, including MPTs.

New HIV prevention findings: Initial HPTN 083 results show long-acting injectable cabotegravir is safe & effective as PrEP for MSM; linked to sister study in women.

"It's all in a decade's work": A Ten-Year Retrospective Report on the IMPT.

The IMPT is the first & only initiative dedicated to advancing the field of multipurpose prevention technologies (MPTs), products that combine HIV prevention, other STI prevention, and contraception.

IMPT Secretariat
1750 Howe Avenue, Suite 550
Sacramento, CA 95825
IMPT@cami-health.org

The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, a social impact organization dedicated to improving the health of women and their families worldwide. CAMI Health is housed at the Public Health Institute (PHI).

This project is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Cooperative Agreement #AID-OAA-A-16-00045. The contents are the responsibility of the IMPT, CAMI Health, PHI, and its partners and do not necessarily reflect the views of USAID or the U.S. Government.